BioInvent International AB (OSTO:BINV) Cyclically Adjusted Book per Share: kr17.98 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:BINV BioInvent International AB OSTO:BINV
37 GF Score
Price kr22.90
GF Value kr7.53
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is BioInvent International AB Cyclically Adjusted Book per Share?

BioInvent International AB OSTO:BINV -0.22% 37 Cyclically Adjusted Book per Share is kr17.98 as of Jun. 2026. GuruFocus rates OSTO:BINV with a GF Score™ of 37/100 and a GF Value™ of kr7.53 (Significantly Overvalued). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

BioInvent International AB's adjusted book value per share for the three months ended in Jun. 2026 was kr4.822. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is kr17.98 for the trailing ten years ended in Jun. 2026.

During the past 12 months, BioInvent International AB's average Cyclically Adjusted Book Growth Rate was -1.40% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 4.50% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 3.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of BioInvent International AB was 7.80% per year. The lowest was -17.10% per year. And the median was -2.90% per year.

As of today (2026-09-10), BioInvent International AB's current stock price is kr22.90. BioInvent International AB's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was kr17.98. BioInvent International AB's Cyclically Adjusted PB Ratio of today is 1.27.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of BioInvent International AB was 3.58. The lowest was 0.83. And the median was 1.85.


BioInvent International AB  (OSTO:BINV) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

BioInvent International AB's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=22.90/17.98
=1.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of BioInvent International AB was 3.58. The lowest was 0.83. And the median was 1.85.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


BioInvent International AB Cyclically Adjusted Book per Share Related Terms


BioInvent International AB Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for BioInvent International AB's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioInvent International AB Cyclically Adjusted Book per Share Chart

BioInvent International AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.43 16.03 17.90 18.06 18.29

BioInvent International AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.23 18.22 18.29 18.33 17.98

OSTO:BINV vs VRTX, REGN, MRNA: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, BioInvent International AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioInvent International AB Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioInvent International AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where BioInvent International AB's Cyclically Adjusted PB Ratio falls into.


OSTO:BINV
37GF Score
BioInvent International AB OSTO:BINV
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioInvent International AB Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, BioInvent International AB's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=4.822/134.6100*134.6100
=4.822

Current CPI (Jun. 2026) = 134.6100.

BioInvent International AB Quarterly Data

Book Value per Share CPI Adj_Book
201609 15.958 101.138 21.239
201612 18.525 102.022 24.442
201703 16.728 102.022 22.071
201706 14.840 102.752 19.441
201709 13.135 103.279 17.120
201712 10.469 103.793 13.577
201803 12.979 103.962 16.805
201806 9.953 104.875 12.775
201809 8.404 105.679 10.705
201812 6.118 105.912 7.776
201903 5.971 105.886 7.591
201906 12.106 106.742 15.267
201909 10.302 107.214 12.934
201912 8.294 107.766 10.360
202003 6.680 106.563 8.438
202006 8.139 107.498 10.192
202009 17.115 107.635 21.404
202012 18.882 108.296 23.470
202103 26.769 108.360 33.254
202106 25.793 108.928 31.874
202109 24.722 110.338 30.160
202112 23.379 112.486 27.977
202203 22.221 114.825 26.050
202206 25.096 118.384 28.536
202209 25.924 122.296 28.534
202212 24.722 126.365 26.335
202303 23.765 127.042 25.181
202306 22.435 129.407 23.337
202309 21.371 130.224 22.091
202312 19.903 131.912 20.310
202403 18.732 132.205 19.073
202406 16.679 132.716 16.917
202409 15.244 132.304 15.510
202412 13.461 132.987 13.625
202503 11.697 132.825 11.854
202506 12.321 133.699 12.405
202509 10.380 133.480 10.468
202512 8.474 133.390 8.552
202603 6.673 133.560 6.725
202606 4.822 134.610 4.822

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of kr17.98 mean?
BioInvent International AB (OSTO:BINV) has a Cyclically Adjusted Book per Share of kr17.98 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on BioInvent International AB and its competitors.
Is BioInvent International AB's Cyclically Adjusted Book per Share too high?
BioInvent International AB's current Cyclically Adjusted Book per Share is kr17.98. Overall, BioInvent International AB has a GF Score™ of 37/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does BioInvent International AB's Cyclically Adjusted Book per Share compare to VRTX and REGN?
BioInvent International AB's Cyclically Adjusted Book per Share of kr17.98 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on BioInvent International AB and its competitors. BioInvent International AB's current Cyclically Adjusted Book per Share is kr17.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioInvent International AB stock overvalued right now?
Based on GuruFocus' analysis, BioInvent International AB (OSTO:BINV) is currently considered Significantly Overvalued. The stock's GF Value™ is kr7.53, compared to a current price of kr22.90 — trading 204.1% above its estimated fair value. The current Cyclically Adjusted Book per Share is kr17.98. BioInvent International AB's overall GF Score™ is 37/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For BioInvent International AB (OSTO:BINV), the current Cyclically Adjusted Book per Share is kr17.98 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BioInvent International AB (OSTO:BINV) Overvalued in 2026?

Based on GuruFocus' analysis, BioInvent International AB stock appears to be overvalued. The current stock price of kr22.90 is trading 204.1% above its estimated GF Value™ of kr7.53. GuruFocus considers BioInvent International AB to be Significantly Overvalued.

Key valuation signals for OSTO:BINV:

  • Cyclically Adjusted Book per Share: kr17.98
  • GF Value™: kr7.53 vs. price of kr22.90 (204.1% above fair value)
  • GF Score™: 37/100 with 7 warning signs

No single metric tells the full story. See the OSTO:BINV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


BioInvent International AB Business Description

Other Exchanges 0H22:UKBIX:Germany
Address Ideongatan 1, Lund, SWE, SE-223 70
BioInvent International AB is a clinical-stage biotech company. It discovers and develops novel and first-in-class immuno-modulatory antibodies for cancer therapy, with currently four drug candidates in five ongoing clinical programs in Phase 1/2 trials for the treatment of hematological cancer and solid tumors, respectively. The company's validated, proprietary F.I.R.S.T technology platform identifies both targets and the antibodies that bind to them, generating many new drug candidates to fuel the company's clinical development pipeline and providing licensing and partnering opportunities. The company's pipeline portfolio comprises BI-1206, an antagonistic blocking antibody for the treatment of non-Hodgkin's lymphoma, and BI-1808 and BI-1910 (anti-TNFR2) for solid cancers.
37GF Score

Get the complete analysis for OSTO:BINV

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr22.90
Price
kr7.53
GF Value